Literature DB >> 19776130

Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.

Yannick Bulliard1, Priscilla Turelli, Ute F Röhrig, Vincent Zoete, Bastien Mangeat, Olivier Michielin, Didier Trono.   

Abstract

Retroelements are important evolutionary forces but can be deleterious if left uncontrolled. Members of the human APOBEC3 family of cytidine deaminases can inhibit a wide range of endogenous, as well as exogenous, retroelements. These enzymes are structurally organized in one or two domains comprising a zinc-coordinating motif. APOBEC3G contains two such domains, only the C terminal of which is endowed with editing activity, while its N-terminal counterpart binds RNA, promotes homo-oligomerization, and is necessary for packaging into human immunodeficiency virus type 1 (HIV-1) virions. Here, we performed a large-scale mutagenesis-based analysis of the APOBEC3G N terminus, testing mutants for (i) inhibition of vif-defective HIV-1 infection and Alu retrotransposition, (ii) RNA binding, and (iii) oligomerization. Furthermore, in the absence of structural information on this domain, we used homology modeling to examine the positions of functionally important residues and of residues found to be under positive selection by phylogenetic analyses of primate APOBEC3G genes. Our results reveal the importance of a predicted RNA binding dimerization interface both for packaging into HIV-1 virions and inhibition of both HIV-1 infection and Alu transposition. We further found that the HIV-1-blocking activity of APOBEC3G N-terminal mutants defective for packaging can be almost entirely rescued if their virion incorporation is forced by fusion with Vpr, indicating that the corresponding region of APOBEC3G plays little role in other aspects of its action against this pathogen. Interestingly, residues forming the APOBEC3G dimer interface are highly conserved, contrasting with the rapid evolution of two neighboring surface-exposed amino acid patches, one targeted by the Vif protein of primate lentiviruses and the other of yet-undefined function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776130      PMCID: PMC2786736          DOI: 10.1128/JVI.01491-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

3.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

4.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

5.  LINE-mediated retrotransposition of marked Alu sequences.

Authors:  Marie Dewannieux; Cécile Esnault; Thierry Heidmann
Journal:  Nat Genet       Date:  2003-08-03       Impact factor: 38.330

6.  APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.

Authors:  Atuhani Burnett; Paul Spearman
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

7.  RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.

Authors:  Hendrik Huthoff; Flavia Autore; Sarah Gallois-Montbrun; Franca Fraternali; Michael H Malim
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

8.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

Review 9.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

10.  APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.

Authors:  Shui-Mei Wang; Chin-Tien Wang
Journal:  Virology       Date:  2009-04-05       Impact factor: 3.616

View more
  39 in total

1.  Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

Authors:  Wenyan Zhang; Juan Du; Kevin Yu; Tao Wang; Xiong Yong; Xiao-Fang Yu
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.

Authors:  Rahul M Kohli; Robert W Maul; Amy F Guminski; Rhonda L McClure; Kiran S Gajula; Huseyin Saribasak; Moira A McMahon; Robert F Siliciano; Patricia J Gearhart; James T Stivers
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 3.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

4.  Biochemical and biological studies of mouse APOBEC3.

Authors:  Smita Nair; Silvia Sanchez-Martinez; Xinhua Ji; Alan Rein
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

5.  Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.

Authors:  Yuqing Feng; Linda Chelico
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

6.  Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.

Authors:  Yannick Bulliard; Iñigo Narvaiza; Alessandro Bertero; Shyam Peddi; Ute F Röhrig; Millán Ortiz; Vincent Zoete; Nataly Castro-Díaz; Priscilla Turelli; Amalio Telenti; Olivier Michielin; Matthew D Weitzman; Didier Trono
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

7.  Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.

Authors:  Michael Letko; Thijs Booiman; Neeltje Kootstra; Viviana Simon; Marcel Ooms
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

8.  Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G.

Authors:  Michael Letko; Guido Silvestri; Beatrice H Hahn; Frederick Bibollet-Ruche; Omer Gokcumen; Viviana Simon; Marcel Ooms
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

9.  Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis.

Authors:  Delphine Lavens; Frank Peelman; José Van der Heyden; Isabel Uyttendaele; Dominiek Catteeuw; Annick Verhee; Bertrand Van Schoubroeck; Julia Kurth; Sabine Hallenberger; Reginald Clayton; Jan Tavernier
Journal:  Nucleic Acids Res       Date:  2009-12-16       Impact factor: 16.971

10.  Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations.

Authors:  Flavia Autore; Julien R C Bergeron; Michael H Malim; Franca Fraternali; Hendrik Huthoff
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.